The Anglo-Swedish pharmaceutical giant plans to build a $1.5 billion manufacturing facility in Singapore to boost its global supply of cancer-killing treatments.
The Anglo-Swedish pharmaceutical giant plans to build a $1.5 billion manufacturing facility in Singapore to boost its global supply of cancer-killing treatments.